DXCM logo

DexCom (DXCM)

Profile

Full Name

DexCom, Inc.

Ticker Symbol

DXCM

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

April 14, 2005

Indexes

S&P 500,NASDAQ 100

Website

http://www.dexcom.com

Employees

10200

Key Details

Price

$69.23(+2.73%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.03B(+11.34% YoY)

Annual EPS

$1.42(+9.23% YoY)

PE ratio

48.41

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$69.23
DXCM price is $69.23

30-Day Relative Volume

0.92
DXCM 30-day relative volume is 0.92

Price Performance

Price Most recent change

+2.73%
DXCM price was up +2.73% on Apr 15, 2025

Price YTD change

-10.98%
DXCM price is down -10.98% since January 1st

Price 1-year change

-48.55%
DXCM price is down -48.55% year-on-year

Price 3-year change

-43.73%
DXCM price is down -43.73% over the past 3 years

Price Range

Price All-time high

$164.86
DXCM price is currently -58.01% below its historical high of $164.86

Price 3-year low

$57.52
DXCM price is currently +20.36% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$27.05B
DXCM market capitalization is $27.05 billion

Market cap 3-year change

-43.96%
DXCM market capitalization is down -43.96% over the past 3 years

Market cap All-time high

$63.12B
DXCM market capitalization is currently -57.14% below its historical high of $63.12 billion

Market cap sector rank

96.38%
DXCM market capitalization is higher than 96.38% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.35%
DXCM shares outstanding is down -1.35% year-on-year

Shares Outstanding 3-Year Change

-0.41%
DXCM shares outstanding is down -0.41% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.75
DXCM beta is 0.75

200-day SMA

$78.60
DXCM price is currently -11.92% below its 200-day simple moving average

50-day SMA

$77.07
DXCM price is currently -10.17% below its 50-day simple moving average

RSI

48.61
DXCM 14-day relative strength index is 48.61

Volume

0.92
DXCM 30-day relative volume is 0.92

ATR

$3.43
DXCM average true range is $3.43

10-day Historical Volatility

79.39%
DXCM 10-day historical volatility is 79.39%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.03B
DXCM annual revenue is $4.03 billion

Revenue Analysts estimate

$4.61B
DXCM annual revenue is currently -12.44% lower than the consensus analysts' forecast

Revenue 1-year change

+11.34%
DXCM annual revenue is up +11.34% year-on-year

Revenue Sector rank

90.71%
DXCM annual revenue is higher than 90.71% of companies in Healthcare sector

EPS

EPS

$1.42
DXCM annual earnings per share is $1.42

EPS Analysts estimate

$2.02
DXCM annual earnings per share is currently -29.73% lower than the consensus analysts' forecast

EPS 1-year change

+9.23%
DXCM annual earnings per share is up +9.23% year-on-year

EPS Sector rank

90.82%
DXCM annual earnings per share is higher than 90.82% of companies in Healthcare sector

Profit

Gross profit

$2.44B
DXCM annual gross profit is $2.44 billion

Gross margin

60.46%
DXCM annual gross profit margin is 60.46%

Operating profit

$600.00M
DXCM annual operating income is $600.00 million

Operating margin

14.88%
DXCM annual operating profit margin is 14.88%

Net income

$576.20M
DXCM annual net profit is $576.20 million

Net margin

14.29%
DXCM annual net profit margin is 14.29%

Expenses

Total expenses

$3.43B
DXCM annual total expenses is $3.43 billion

Operating expenses

$1.84B
DXCM annual total operating expenses is $1.84 billion

Cost of goods sold

$1.59B
DXCM annual cost of goods sold is $1.59 billion

Selling, general & administrative expenses

$1.29B
DXCM annual SGA is $1.29 billion

Depreciation and amortization

$217.70M
DXCM annual depreciation & amortization is $217.70 million

Interest expense

$19.00M
DXCM annual interest expense is $19.00 million

Income tax

$132.80M
DXCM annual income tax is $132.80 million

EBIT & EBITDA

EBIT

$600.00M
DXCM annual earnings before interest & taxes is $600.00 million

EBITDA

$600.00M
DXCM annual EBITDA is $600.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$6.48B
DXCM annual total assets is $6.48 billion

Non current assets

$2.18B
DXCM annual long term assets is $2.18 billion

Current assets

$4.30B
DXCM annual total current assets is $4.30 billion

Cash and cash equivalents

$606.10M
DXCM annual cash & cash equivalents is $606.10 million

Accounts receivable

$1.01B
DXCM annual accounts receivable is $1.01 billion

Inventory

$542.60M
DXCM annual inventory is $542.60 million

Liabilities

Total liabilities

$4.38B
DXCM annual total liabilities is $4.38 billion

Long term liabilities

$1.45B
DXCM annual total long term liabilities is $1.45 billion

Current liabilities

$2.93B
DXCM annual total current liabilities is $2.93 billion

Accounts payable

$345.30M
DXCM annual accounts payable is $345.30 million

Debt

Total debt

$2.59B
DXCM annual total debt is $2.59 billion

Total debt 1-year change

-0.25%
DXCM annual total debt is down -0.25% year-on-year

Long term debt

$1.36B
DXCM annual long term debt is $1.36 billion

Short term debt

$1.23B
DXCM annual short term debt is $1.23 billion

Equity & Capital

Shareholders equity

$2.10B
DXCM annual stockholders equity is $2.10 billion

Book value

$2.10B
DXCM annual book value is $2.10 billion

Retained earnings

$1.60B
DXCM annual retained earnings is $1.60 billion

Working capital

$1.37B
DXCM annual working capital is $1.37 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$989.50M
DXCM annual cash flow from operations is $989.50 million

Cash from operations 1-year change

+32.2%
DXCM annual cash flow from operations is up +32.2% year-on-year

Cash from investing

-$207.50M
DXCM annual cash flow from investing activities is -$207.50 million

Cash from investing 1-year change

+59.09%
DXCM annual cash flow from investing activities is up +59.09% year-on-year

Cash from financing

-$734.80M
DXCM annual cash flow from financing activities is -$734.80 million

Cash from financing 1-year change

-130.63%
DXCM annual cash flow from financing activities is down -130.63% year-on-year

CAPEX

CAPEX

$358.80M
DXCM annual capital expenditures is $358.80 million

CAPEX 1-year change

+51.65%
DXCM annual capital expenditures is up +51.65% year-on-year

Free Cash Flow

Free cash flow

$630.70M
DXCM annual free cash flow is $630.70 million

Free cash flow 1-year change

+23.21%
DXCM annual free cash flow is up +23.21% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

60.46%
DXCM annual gross profit margin is 60.46%

Operating margin

14.88%
DXCM annual operating profit margin is 14.88%

Net margin

14.29%
DXCM annual net profit margin is 14.29%

ROA & ROE

ROA

9.04%
DXCM annual return on assets is 9.04%

ROE

27.63%
DXCM annual return on equity is 27.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

48.41
DXCM price to earnings ratio is 48.41

PE ratio Sector rank

78.43%
DXCM price to earnings ratio is higher than 78.43% of companies in Healthcare sector

PB Ratio

PB ratio

12.87
DXCM price to book ratio is 12.87

PB ratio Sector rank

94.9%
DXCM price to book ratio is higher than 94.9% of companies in Healthcare sector

PS Ratio

PS ratio

6.71
DXCM price to sales ratio is 6.71

PS ratio Sector rank

72.69%
DXCM price to sales ratio is higher than 72.69% of companies in Healthcare sector

Enterprise value

Enterprise value

$29.03B
DXCM enterprise value is $29.03 billion

Enterprise value Sector rank

96.2%
DXCM enterprise value is higher than 96.2% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

33.74
DXCM EV/EBITDA is 33.74

EV/EBITDA Sector rank

95.48%
DXCM EV/EBITDA is higher than 95.48% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.47
DXCM annual current ratio is 1.47

Quick ratio

1.28
DXCM annual quick ratio is 1.28

Leverage

Debt to equity

1.16
DXCM annual debt to equity ratio is 1.16

Interest coverage ratio

31.58
DXCM annual interest coverage ratio is 31.58

Risk & Stability

Piotroski F-Score

6
DXCM piotroski f-score is 6

Altman Z-Score

5.23
DXCM altman z-score is 5.23

Analyst ratings

Recent major analysts updates

Apr 10, 25 Mizuho
Outperform
Mar 4, 25 Citigroup
Buy
Feb 14, 25 Morgan Stanley
Equal-Weight
Feb 14, 25 Canaccord Genuity
Buy
Feb 3, 25 Redburn Atlantic
Buy
Jan 16, 25 Baird
Outperform
Dec 11, 24 Wells Fargo
Overweight
Dec 11, 24 Citigroup
Buy
Dec 9, 24 Canaccord Genuity
Buy
Oct 25, 24 Wells Fargo
Overweight

Institutional Ownership

Similar stocks

IQV logo
IQVIA Holdings (IQV)
BeiGene (ONC)
GEHC logo
GE HealthCare Technologies (GEHC)
A logo
Agilent Technologies (A)
ALNY logo
Alnylam Pharmaceuticals (ALNY)
BNTX logo
BioNTech SE (BNTX)
CNC logo
Centene (CNC)
RMD logo
ResMed (RMD)
PHG logo
Koninklijke Philips NV (PHG)
  • What is the ticker symbol for DexCom?
  • Does DexCom pay dividends?
  • What sector is DexCom in?
  • What industry is DexCom in?
  • What country is DexCom based in?
  • When did DexCom go public?
  • Is DexCom in the S&P 500?
  • Is DexCom in the NASDAQ 100?
  • Is DexCom in the Dow Jones?
  • When was DexCom's last earnings report?
  • When does DexCom report earnings?
  • Should I buy DexCom stock now?

What is the ticker symbol for DexCom?

The ticker symbol for DexCom is NASDAQ:DXCM

Does DexCom pay dividends?

No, DexCom does not pay dividends

What sector is DexCom in?

DexCom is in the Healthcare sector

What industry is DexCom in?

DexCom is in the Medical Devices industry

What country is DexCom based in?

DexCom is headquartered in United States

When did DexCom go public?

DexCom's initial public offering (IPO) was on April 14, 2005

Is DexCom in the S&P 500?

Yes, DexCom is included in the S&P 500 index

Is DexCom in the NASDAQ 100?

Yes, DexCom is included in the NASDAQ 100 index

Is DexCom in the Dow Jones?

No, DexCom is not included in the Dow Jones index

When was DexCom's last earnings report?

DexCom's most recent earnings report was on Feb 13, 2025

When does DexCom report earnings?

The next expected earnings date for DexCom is May 1, 2025

Should I buy DexCom stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page